Cargando…
Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
While the optimal treatment concept of medication-related osteonecrosis of the jaws (MRONJ) is still in debate, several adjunct therapies have been introduced. Among these adjunctive measures, recombinant human parathyroid hormone (rhPTH, teriparatide) seems to be the most promising treatment modali...
Autores principales: | Kwon, Yong-Dae, Kim, Deog-Yoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806950/ https://www.ncbi.nlm.nih.gov/pubmed/29563483 http://dx.doi.org/10.3390/dj4040041 |
Ejemplares similares
-
Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Otto, Sven, et al.
Publicado: (2021) -
Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ)
por: Yan, Ran, et al.
Publicado: (2022) -
Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Laimer, Johannes, et al.
Publicado: (2021) -
Association between Hyperglycemia and Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Kammerhofer, Gabor, et al.
Publicado: (2023) -
Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ)
por: Berg, Britt-Isabelle, et al.
Publicado: (2016)